Mathilde Kaper
Impact in
- Urology top 2%
- Urinary Bladder and Prostate Research
-
- Cancer Genomics and Diagnostics
Papers in
-
- Glycosylation and Glycoproteins Research 2
- Melanoma and MAPK Pathways 2
- Urology 5
- Urinary Bladder and Prostate Research 5
- Co-authors
- Paul Abrams (3 shared papers)Andrew Gammie (4 shared papers)Caroline A. Dorrepaal (4 shared papers)Farhat Ghaznawi (3 shared papers)Michelle C. Miller (4 shared papers)Mario Campone (3 shared papers)Gábor Rubovszky (2 shared papers)Toshinari Yamashita (2 shared papers)
- Journals
- Annals of Oncology (4 papers)Blood (4 papers)Neurourology and Urodynamics (3 papers)Cancer Research (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesIsraelSwitzerland
In The Last Decade
Mathilde Kaper
17 papers receiving 900 citations
Mathilde Kaper's Hit Papers
Peers
Comparison fields: 5 of 62
- Urology 170
- Cancer Research 136
- Physiology 234
- Oncology 195
- Pulmonary and Respiratory Medicine 212
Countries citing papers authored by Mathilde Kaper
This map shows the geographic impact of Mathilde Kaper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Kaper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Kaper more than expected).
Fields of papers citing papers by Mathilde Kaper
This network shows the impact of papers produced by Mathilde Kaper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Kaper. The network helps show where Mathilde Kaper may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathilde Kaper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1 Hit paper breakdown → | 2020 | 391 |
| 2 | 2015 | 123 | |
| 3 | 2010 | 122 | |
| 4 | 2010 | 120 | |
| 5 | 2015 | 63 | |
| 6 | 2018 | 23 | |
| 7 | 2018 | 16 | |
| 8 | 2020 | 16 | |
| 9 | 2020 | 12 | |
| 10 | 2018 | 9 | |
| 11 | 2021 | 7 | |
| 12 | 2018 | 7 | |
| 13 | 2023 | 4 | |
| 14 | Flow time and voiding time – definitions and use in identifying detrusor underactivity | 2016 | 3 |
| 15 | 2009 | 3 | |
| 16 | 2010 | 1 | |
| 17 | 2018 | 1 |
About Mathilde Kaper
Mathilde Kaper is a scholar working on Molecular Biology, Urology, Oncology, Physiology and Organic Chemistry, having authored 17 papers that have together received 921 indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (5 papers), Lysosomal Storage Disorders Research (4 papers), Cancer Treatment and Pharmacology (3 papers), Advanced Breast Cancer Therapies (3 papers), HER2/EGFR in Cancer Research (3 papers), Trypanosoma species research and implications (2 papers), Glycosylation and Glycoproteins Research (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Urology (170 citations), Cancer Research (136 citations), Physiology (234 citations), Oncology (195 citations) and Pulmonary and Respiratory Medicine (212 citations). Mathilde Kaper has collaborated with scholars based in United States, Israel and Switzerland. Frequent co-authors include Paul Abrams, Andrew Gammie, Caroline A. Dorrepaal, Farhat Ghaznawi, Michelle C. Miller, Mario Campone, Gábor Rubovszky, Toshinari Yamashita, Hope S. Rugo and Fabrice André. Their work appears in journals such as Annals of Oncology, Blood, Neurourology and Urodynamics, Cancer Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.